Furthermore, there was no significant difference in haplotypic risks on abstinence or relapse between different active treatment groups (Bupropion only, NRT only, and Combined) (Table S5), and no association between haplotypes and abstinence or relapse in any specific medication groups (Figures S2, S4). Additional analyses using single SNPs showed consistent results (Tables S6, S7).
